NYSE: SOLVSolventum Corp Stock
$73.51+0.82 (+1.13%)
Updated Jan 17, 2025
SOLV Price
$73.51
Fair Value Price
N/A
Market Cap
$12.70B
52 Week Low
$47.16
52 Week High
$77.17
P/E
N/A
P/B
3.98x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
3.62
Operating Cash Flow
N/A
Beta
0.58
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SOLV's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Value
C
Growth
C
Momentum
C
Sentiment
B
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
C
SOLV
Ranked#20 of 51
Ranked#20 of 51
Be the first to know about important SOLV news, forecast changes, insider trades & much more!
SOLV News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SOLV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SOLV is poor value based on its book value relative to its share price (3.98x), compared to the US Health Information Services industry average (3.79x)
P/B vs Industry Valuation
SOLV's short-term assets ($3.35B) exceed its short-term liabilities ($2.90B)
Short-term Liabilities Financials
SOLV's long-term liabilities ($8.65B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more SOLV due diligence checks available for Premium users.
Valuation
SOLV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.98x
Industry
3.79x
SOLV is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SOLV's financial health
Profit margin
Revenue
$2.1B
Net Income
$122.0M
Profit Margin
5.9%
Assets to liabilities
Assets
$14.7B
Liabilities
$11.6B
Debt to equity
3.62
SOLV's short-term assets ($3.35B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SOLV's long-term liabilities ($8.65B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SOLV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$169.0M
Investing
-$93.0M
Financing
-$202.0M
SOLV vs Health Information Service Stocks
Solventum Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.